Funding Opportunities

NIH Funding Opportunities

Notice of Clarification of Instructions for the Description of the Program Advisory Committee in RFA-AA-15-001 "Specialized Alcohol Research Centers (P50)"
Notice NOT-AA-14-013 from the NIH Guide for Grants and Contracts
Fri, 17 Oct 2014 02:04:39 EST

Notice of Clarification of Instructions for the Description of the Program Advisory Committee in RFA-AA-15-002 "Specialized Alcohol Research Centers (P60)"
Notice NOT-AA-14-014 from the NIH Guide for Grants and Contracts
Fri, 17 Oct 2014 02:12:44 EST

Notice of Correction to Number of Applications per Institution Allowed and FOA Expiration Date in PAR-14-356 "The Midlife in the United States Study (U19)"
Notice NOT-AG-14-026 from the NIH Guide for Grants and Contracts
Tue, 14 Oct 2014 03:46:51 EST

Notice of NIAID's Participation in PA-14-307 "Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)"
Notice NOT-AI-15-002 from the NIH Guide for Grants and Contracts
Wed, 15 Oct 2014 09:33:37 EST

Notice of NIAID's Participation in PA-14-308 "Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)"
Notice NOT-AI-15-003 from the NIH Guide for Grants and Contracts
Wed, 15 Oct 2014 09:22:57 EST

Notice of Availability of Funds for Competitive Revision Applications for Research to Determine if Reduction in Illicit Drug Use is Associated with Improvement in Clinical Outcome(s)
Notice NOT-DA-14-049 from the NIH Guide for Grants and Contracts
Thu, 16 Oct 2014 02:00:47 EST

Notice of Participation of the National Institute on Drug Abuse in PA-14-334 "Advancing Interventions to Improve Medication Adherence (R01)"
Notice NOT-DA-14-052 from the NIH Guide for Grants and Contracts
Fri, 17 Oct 2014 12:23:09 EST

Notice of Technical Assistance Webinar for RFA-ES-14-002 "Children's Environmental Health and Disease Prevention Research Centers (P50)"
Notice NOT-ES-15-001 from the NIH Guide for Grants and Contracts
Wed, 15 Oct 2014 01:59:33 EST

Notice to Clarify Underrepresented Groups for PAR-13-196 "Research Initiative for Scientific Enhancement (RISE) (R25)"
Notice NOT-GM-14-131 from the NIH Guide for Grants and Contracts
Wed, 15 Oct 2014 10:36:44 EST

Notice to Clarify Underrepresented Groups for PAR-14-121 "Initiative for Maximizing Student Development (IMSD) (R25)"
Notice NOT-GM-14-132 from the NIH Guide for Grants and Contracts
Wed, 15 Oct 2014 10:32:31 EST

NHLBI Announces Frequently Asked Questions (FAQs) for RFA-HL-15-015 "Multi-Site Clinical Trials for the Pulmonary Trials Cooperative (U01)" and RFA-HL-15-016 "Network Management Core (NEMO) for the Pulmonary Trials Cooperative (U01)"
Notice NOT-HL-14-240 from the NIH Guide for Grants and Contracts
Wed, 15 Oct 2014 02:11:38 EST

AHRQ Implements the Research Performance Progress Report (RPPR) and Uniform Progress Report Due Dates
Notice NOT-HS-15-001 from the NIH Guide for Grants and Contracts
Fri, 17 Oct 2014 02:42:38 EST

Notice Announcing Frequently Asked Questions (FAQs) for RFA-MH-15-850 "Gut-Microbiome-Brain Interactions and Mental Health (R21/R33)"
Notice NOT-MH-15-003 from the NIH Guide for Grants and Contracts
Thu, 16 Oct 2014 02:38:23 EST

Notice of Special Accommodations for Submission and Reporting Requirements for Program Directors/Principal Investigators Responding to the West Africa Ebola Outbreak
Notice NOT-OD-15-010 from the NIH Guide for Grants and Contracts
Thu, 16 Oct 2014 11:21:19 EST

Funding Pause for Certain Types of Gain-of-Function Research Projects
Notice NOT-OD-15-011 from the NIH Guide for Grants and Contracts
Fri, 17 Oct 2014 04:26:35 EST

Notice to Extend the Response Date for NOT-OD-14-128 "Request for Information (RFI): Consideration of Sex As a Biological Variable in Biomedical Research"
Notice NOT-OD-15-012 from the NIH Guide for Grants and Contracts
Wed, 15 Oct 2014 09:06:21 EST

Reminder: NIH Requires the Research Performance Progress Report (RPPR) for All Type 5 Progress Reports
Notice NOT-OD-15-014 from the NIH Guide for Grants and Contracts
Thu, 16 Oct 2014 03:49:01 EST

Notice to Clarify Category Limit for Salary Costs for RFA-TW-14-002 "Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research Training (U2R)"
Notice NOT-TW-15-001 from the NIH Guide for Grants and Contracts
Wed, 15 Oct 2014 09:56:10 EST

Innovative Technologies for Differential Diagnosis of Acute Febrile Illnesses (R21/R33)
Funding Opportunity RFA-AI-14-062 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for early-stage translational research projects focused on the development of innovative, unbiased next generation, differential diagnostic technologies for acute febrile illnesses caused by infectious pathogens, excluding HIV.
Wed, 15 Oct 2014 02:53:17 EST

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers (CSCPDPC -CCs) (U01)
Funding Opportunity RFA-DK-14-027 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U01 applications for the establishment of a clinical consortium, composed of one Coordination and Data Management Center (CDMC) and up to 9 Clinical Centers (CC), to conduct studies on chronic pancreatitis (CP) and factors that increase the risk of pancreatic cancer in patients (children and adults) with CP, pancreatogenic (type 3c) diabetes (T3cDM) and in patients with newly diagnosed diabetes. The Consortium will form multi-disciplinary teams composed of members from the CCs and CDMC to undertake a comprehensive clinical, epidemiological and biological characterization of patients with CP (including those with Acute Recurrent Pancreatitis, ARP) to gain insight into the pathophysiology of chronic pancreatitis and its sequela: chronic pain, pancreatic insufficiency, T3cDM and the diabetes/pancreatic cancer association. The teams will also undertake studies on the development of pancreatic cancer in newly diagnosed diabetic patients. Applications for the Consortium Coordination and Data Management Center (CDMC) are being solicited via RFA-DK-14-028 "Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Coordination and Data Coordinating Center (CSCPDPC-CDMC) (U01)". To achieve the goal of a comprehensive characterization of evolving chronic pancreatitis and pancreatic cancer, each CC should include researchers and clinicians with multi-disciplinary expertise. Research CCs will be expected to share results freely within Consortium and to develop trans-Consortium collaborative projects that make use of the combined expertise and technological capabilities present in all of the CCs. In addition, a major collaborative effort within the Consortium will be the establishment of an annotated repository of biospecimens (blood, pancreatic and duodenal juice, stools and when feasible pancreatic tissue) to allow for the identification and validation of biomarkers for risk stratification and/or early detection.
Fri, 17 Oct 2014 01:38:56 EST

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Coordination and Data Management Center (CSCPDPC- CDMC) (U01)
Funding Opportunity RFA-DK-14-028 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U01 applications for the establishment of a clinical consortium, composed of one Coordination and Data Management Center (CDMC) and up to 9 Clinical Centers (CC), to conduct studies on chronic pancreatitis (CP) and factors that increase the risk of pancreatic cancer in patients (children and adults) with CP, pancreatogenic (type 3c) diabetes (T3cDM) and in patients with newly diagnosed diabetes. The Consortium will form multi-disciplinary teams composed of members from the CCs and CDMC to undertake a comprehensive clinical, epidemiological and biological characterization of patients with CP (including those with Acute Recurrent Pancreatitis, ARP) to gain insight into the pathophysiology of chronic pancreatitis and its sequela: chronic pain, pancreatic insufficiency, T3cDM and the diabetes/pancreatic cancer association. The teams will also undertake studies on the development of pancreatic cancer in newly diagnosed diabetic patients. Applications for the consortium Clinical Centers are being solicited via RFA-DK-14-027 "Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers (CSCPDPC-CCs) (U01)". To achieve the goal of a comprehensive characterization of evolving chronic pancreatitis and pancreatic cancer, the Coordinating and Data Management Center (CDMC) will take on the administrative and data collection/analysis functions and will be responsible for the conduct of all of the ongoing and future studies of the CCs. In addition, a major collaborative effort within the Consortium will be the establishment of an annotated repository of bio-specimens (blood, pancreatic and duodenal juice, stools and when feasible pancreatic tissue) to allow for the identification and validation of biomarkers for risk stratification and/or early detection.
Fri, 17 Oct 2014 01:53:44 EST

NINDS Institutional Center Core Grants to Support Neuroscience Research (P30)
Funding Opportunity RFA-NS-14-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for Center Core Grants that provide resources and facilities shared by a minimum of six NINDS-supported investigators, and supporting a wider base of neuroscience research. The proposed Centers should offer services and expertise that would be difficult or impractical to support in individual labs. The Centers are expected to capitalize on economies and synergies associated with shared resources, and to foster a collaborative environment among neuroscientists at host institutions.
Tue, 14 Oct 2014 04:11:33 EST

Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21)
Funding Opportunity PA-15-015 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research focused on biobehavioral or technological interventions to attenuate cognitive decline in individuals with dementia (such as Alzheimers disease, Lewy body dementia, vascular dementia), mild cognitive impairment (MCI), or disease- or age-related cognitive decline. There is particular interest in interventions that can be implemented in community settings by the affected individual, informal caregivers, or others in the community. Research to inform the development of such interventions is also of interest, as well as research examining underlying mechanisms and biomarkers associated with response to interventions. It is anticipated that the results of this research will help affected individuals maintain independence and quality of life, improve their ability to perform activities of daily living (ADLs) and instrumental activities of daily living (IADLs), and additionally help to reduce stress, burden, and other poor outcomes in their caregivers.
Tue, 14 Oct 2014 11:10:30 EST

Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15)
Funding Opportunity PA-15-016 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research focused on biobehavioral or technological interventions to attenuate cognitive decline in individuals with dementia (such as Alzheimers disease, Lewy body dementia, vascular dementia), mild cognitive impairment (MCI), or disease- or age-related cognitive decline. There is particular interest in interventions that can be implemented in community settings by the affected individual, informal caregivers, or others in the community. Research to inform the development of such interventions is also of interest, as well as research examining underlying mechanisms and biomarkers associated with response to interventions. It is anticipated that the results of this research will help affected individuals maintain independence and quality of life, improve their ability to perform activities of daily living (ADLs) and instrumental activities of daily living (IADLs), and additionally help to reduce stress, burden, and other poor outcomes in their caregivers.
Wed, 15 Oct 2014 02:36:32 EST

Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01)
Funding Opportunity PA-15-017 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research focused on biobehavioral or technological interventions to attenuate cognitive decline in individuals with dementia (such as Alzheimers disease, Lewy body dementia, vascular dementia), mild cognitive impairment (MCI), or disease- or age-related cognitive decline. There is particular interest in interventions that can be implemented in community settings by the affected individual, informal caregivers, or others in the community. Research to inform the development of such interventions is also of interest, as well as research examining underlying mechanisms and biomarkers associated with response to interventions. It is anticipated that the results of this research will help affected individuals maintain independence and quality of life, improve their ability to perform activities of daily living (ADLs) and instrumental activities of daily living (IADLs), and additionally help to reduce stress, burden, and other poor outcomes in their caregivers.
Tue, 14 Oct 2014 12:00:59 EST

Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Diseases Clinical Research Network (U54)
Funding Opportunity PAR-15-019 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is limited to those Program Director(s)/Principal Investigator(s) of Rare Diseases Clinical Research Consortia (RDCRC) who received an NINDS award under the Rare Diseases Clinical Research Network (RDCRN) program through RFA-TR-13-002, or an NCI award through RFA-OD-08-001. The purpose of this limited competition FOA is to allow these NINDS- and NCI-awarded consortia an opportunity to compete for another four years of participation in the RDCRN. The RDCRN is a collaborative and coordinated network of Clinical Research Consortia comprised of investigators and patient advocacy groups committed to investigation of rare diseases working in partnership with a Data Management Coordinating Center (http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-13-003.html) to enhance communication and sharing of resources in a multidisciplinary approach. This FOA intends to support: 1) collaborative clinical research in rare diseases, including longitudinal studies of individuals with rare diseases, clinical studies and/or clinical trials; 2) career development and advancement opportunities for clinical investigators in rare diseases research; 3) pilot/demonstration (proof of concept) clinical research projects; and 4) access to information related to rare diseases for basic and clinical researchers, physicians, patients, and the lay public.
Thu, 16 Oct 2014 01:52:12 EST

Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01)
Funding Opportunity PAR-15-020 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to promote systems developmental biology. In the context of this FOA, systems developmental biology is defined as research focused on understanding how biological components work together to produce the complex biological phenomena encompassing embryonic development.
Thu, 16 Oct 2014 11:37:03 EST